It was first described in 1998
Andjar-Snchez M et al
What are the legal risks of DIY GLP-1 injections

Cell cycle scoring We downloaded the Regev lab cell cycle genes, as used in Seurat and the scverse tutorials and converted the genes to mouse nomenclature using BioMart ( Pandey GADD45B, CAMK2D, CNTN1, VIM, NUPR1, SLC3A2, FOS, JUNB, JUN, DDIT3, KLK6, CD63, HMGB2, DYNLL1, CSF1, B2M, FBL, KLF6 IRAS1 CCL2, CCL20, CSF3, CXCL1, CXCL2, CXCL3, CXCL5, FTH1, PDCD5, PDLIM4, PITX3, PSME2, SERPINE1, SOD2, TNFAIP6 IRAS2 B2M, CALR, CARHSP1, CCL2, CD47, FTH1, ICAM1, LAP3, NFKBIA, NNMT, PDCD5, PFN1, PKM, PRELID1, PSME2, SOD2, TMSB10, VCAM1 Common innate immunity IFI47, IIGP1, MDFIC, TOP2A, DYNLT1A, LGALS1, CXCL10, OASL1, ZBP1, DHX58, TRIM25, RSAD2, SLFN9, OAS1A, IFITM2, BCL3, IFI27L2A, OASL2, IRF7, IFIT1, BST2, ISG15, IFIT3B, IFIT3, IFITM3, RTP4 CPZ DAO signature SPRY2, SYT4, CHCHD10, DTHD1, TRIB3, EPHA5, NUPR1, ATF4, CYB5R2, DDIT3, GDF15, CD44, CEBPG, VEGFA, CDH6, SLC7A5, S100A6, CDKN1A, RGS20, LMNA, VIM, EGR1 Remyelination DAO signature COL6A1, GADD45G, COL27A1, COL6A2, NAV3, TMEM176A, COL13A1, FGFRL1, SNX10, PARP3, CXCL14, NRTN, SOCS3, ANXA2, TNFRSF1A, BCL3, B2M, PLVAP, GADD45B, SEMA4F Hypoxia signature ANXA2, BHLHE40, CHST2, ENO2, FOSL2, GCNT2, GLRX, HMOX1, ISG20, MIF, MXI1, NDRG1, NFIL3, NOCT, P4HA1, PAM, PGK1, PGM1, PIM1, PLAC8, PLAUR, PLIN2, PRDX5, SDC2, SDC3, TGFBI, TPD52, TPI1, VEGFA Inflammatory response signature ABCA1, AQP9, AXL, BST2, CCL5, CD14, CD48, CHST2, CLEC5A, HIF1A, HRH1, ICAM1, IL1B, IL10, IL15, IL18R1, IL1R1, MARCO, MSR1, MXD1, NAMPT, NOD2, PLAUR, PTGER4, RNF144B, SLC31A2, STAB1, TLR2 Meta-neighborhood analysis To determine cluster similarity in our cross-species analysis, we used MetaNeighbor 72

[PMID: 8147899] PubMed record related to this compound for laboratory literature review
(46), where water-soluble QUE (corvitin) stabilized oxidative balance in rats with bacterial-immune periodontitis by reducing superoxide dismutase activity and sustaining catalase and ceruloplasmin levels